Patents Assigned to Stanley Research Foundation
  • Patent number: 5139023
    Abstract: The present invention is directed to novel methods and apparatus for noninvasive blood glucose monitoring. Blood glucose is monitored noninvasively by correlation with amount of glucose which permeates an epithelial membrane, such as skin or a mucosal membrane, into a glucose receiving medium over a specified time period. The glucose receiving medium preferably includes a glucose permeation enhancer capable of increasing the glucose permeability across the epithelial membrane. The glucose receiving medium is positioned against the epithelial membrane so that the permeation enhancer alters the permeability of the membrane. After sufficient time delay, the glucose receiving medium is removed and analyzed for the presence of glucose using conventional analytical techniques.The apparatus within the scope of the present invention includes means for supporting the glucose receiving medium.
    Type: Grant
    Filed: June 2, 1989
    Date of Patent: August 18, 1992
    Assignees: TheraTech Inc., Stanley Research Foundation
    Inventors: Theodore H. Stanley, Charles D. Ebert, William I. Higuchi, Jie Zhang